These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8151263)

  • 21. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.
    Vanhoutte PM; Zhao Y; Xu A; Leung SW
    Circ Res; 2016 Jul; 119(2):375-96. PubMed ID: 27390338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nitric oxide and circulatory homeostasis].
    Arnal JF
    Ann Cardiol Angeiol (Paris); 1997; 46(7):420-5. PubMed ID: 9452776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications.
    Rongen GA; Smits P; Thien T
    Neth J Med; 1994 Jan; 44(1):26-35. PubMed ID: 8202203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction: clinical implications.
    Drexler H
    Prog Cardiovasc Dis; 1997; 39(4):287-324. PubMed ID: 9050817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.
    Dakak N; Husain S; Mulcahy D; Andrews NP; Panza JA; Waclawiw M; Schenke W; Quyyumi AA
    Hypertension; 1998 Jul; 32(1):9-15. PubMed ID: 9674631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
    Cleland SJ; Petrie JR; Ueda S; Elliott HL; Connell JM
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):175-84. PubMed ID: 9590566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction.
    Kelm M; Preik M; Hafner DJ; Strauer BE
    Hypertension; 1996 Mar; 27(3 Pt 1):346-53. PubMed ID: 8698436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipids and the endothelium.
    Dart AM; Chin-Dusting JP
    Cardiovasc Res; 1999 Aug; 43(2):308-22. PubMed ID: 10536661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches.
    Yzydorczyk C; Armengaud JB; Peyter AC; Chehade H; Cachat F; Juvet C; Siddeek B; Simoncini S; Sabatier F; Dignat-George F; Mitanchez D; Simeoni U
    J Dev Orig Health Dis; 2017 Aug; 8(4):448-464. PubMed ID: 28460648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide and endothelium-dependent hyperpolarization mediated by hydrogen peroxide in health and disease.
    Shimokawa H; Godo S
    Basic Clin Pharmacol Toxicol; 2020 Aug; 127(2):92-101. PubMed ID: 31846200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Drugs; 2002; 62(2):265-84. PubMed ID: 11817973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of nitric oxide in cardiovascular disease: focus on the endothelium.
    Cannon RO
    Clin Chem; 1998 Aug; 44(8 Pt 2):1809-19. PubMed ID: 9702990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The physiology and pathophysiology of the nitric oxide/superoxide system.
    Münzel T; Heitzer T; Harrison DG
    Herz; 1997 Jun; 22(3):158-72. PubMed ID: 9232165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications.
    Zaric B; Obradovic M; Trpkovic A; Banach M; Mikhailidis DP; Isenovic ER
    Curr Med Chem; 2020; 27(7):1021-1040. PubMed ID: 31480995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.